KNSA earnings: real EPS beat/miss history, analyst consensus Buy, P/E 63.71. Updated 2026-07-23.
Kiniksa Pharmaceuticals International (KNSA) Research Hub
Kiniksa Pharmaceuticals International (KNSA) trades on NASDAQ, GB in the Healthcare (Medical - Pharmaceuticals) sector. As of 2026-09-11, shares last closed at 76.27 USD (-2.87%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 63.71, market cap 4.65B. This hub links to the full technical, earnings and options research available for KNSA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Pharmaceuticals) |
|---|---|
| Exchange | NASDAQ, GB |
| Last close | 76.27 USD (-2.87%) |
| 52-week range | 51.7 USD – 82.94 USD |
| Trend regime | Range |
| 14-day RSI | 50.5 (Neutral) |
| Trailing P/E | 63.71 |
| Market cap | 4.65B |
| Dividend yield | 0.00% |
Available research for KNSA
Covered Call on KNSA: how it works, illustrative setup around the real 76.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on KNSA: how it works, illustrative setup around the real 76.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on KNSA: how it works, illustrative setup around the real 76.27 USD price, max profit/loss, breakeven and when to use it. Educational.
KNSA technical analysis: range, last 76.27 USD, RSI 50.5, 52w range 51.7 USD–82.94 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is KNSA in?
Kiniksa Pharmaceuticals International (KNSA) is classified under Healthcare (Medical - Pharmaceuticals), listed on NASDAQ, GB.
Is KNSA in an uptrend or downtrend?
As of 2026-09-11, KNSA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is KNSA's trailing P/E ratio?
KNSA's trailing P/E is 63.71, with a market cap of 4.65B. See the earnings research page for full valuation detail.